发明名称 POST NASAL DRIP TREATMENT
摘要 Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.
申请公布号 US2015202003(A1) 申请公布日期 2015.07.23
申请号 US201514675689 申请日期 2015.03.31
申请人 AERIN MEDICAL INC. 发明人 WOLF Scott J.;FRAZIER Andrew
分类号 A61B18/14;A61M25/10;A61B18/02 主分类号 A61B18/14
代理机构 代理人
主权项 1. A method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough, the method comprising: advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient; contacting mucosal tissue of the upper airway with the treatment delivery portion, without piercing the mucosal tissue; and delivering a treatment from the treatment delivery portion to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.
地址 Sunnyvale CA US